Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection
Abstract The prevalence of Mycobacterium avium complex-pulmonary disease (MAC-PD) has become a growing concern worldwide, and current treatments involving macrolides (clarithromycin [CLR] or azithromycin), ethambutol, and rifampicin have limited success, highlighting the need for better therapeutic...
| 出版年: | Scientific Reports |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Nature Portfolio
2023-11-01
|
| オンライン･アクセス: | https://doi.org/10.1038/s41598-023-48001-y |